We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Benjamin J. Hindson, the See Remarks of $TXG, sold 4,573 shares of the company on 02-24-2025 for an estimated $50,602. We received data on the trade from a recent SEC ...
ALAN MATEO, a director at $TXG, bought 40,000 shares of the company on 02-21-2025 for an estimated $445,572. This trade was reported by Quiver Quantitative using data ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...
In our recent Legion Tower 7 review, Jacqueline Thomas wrote that "the Legion Tower 7i is an incredibly powerful gaming PC, especially for the money you’re likely going to be paying for it.
You'll get the most out of your Lenovo Legion Go S handheld with these accessories and add-ons. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.
The Lenovo Legion Go S is an incredibly ergonomic handheld gaming PC that feels great in your hands. But Windows makes the whole experience feel awkward. The Steam Deck OLED offers better battery ...
Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.
Hosted on MSN29d
Leerink Partners Downgrades 10x Genomics (TXG)Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Outperform to Market Perform. Analyst Price Forecast Suggests 71.13% Upside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results